Northern Trust’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.25M Buy
529,284
+8,275
+2% +$79.3K ﹤0.01% 2545
2025
Q4
$6.07M Sell
521,009
-10,494
-2% -$102K ﹤0.01% 2360
2025
Q3
$5.34M Buy
531,503
+46,489
+10% +$667K ﹤0.01% 2459
2025
Q2
$8.46M Sell
485,014
-2,029
-0.4% -$29.3K ﹤0.01% 2167
2025
Q1
$6.13M Buy
487,043
+8,890
+2% +$107K ﹤0.01% 2314
2024
Q4
$5.04M Buy
478,153
+25,773
+6% +$361K ﹤0.01% 2500
2024
Q3
$6.56M Buy
452,380
+184,809
+69% +$2.2M ﹤0.01% 2320
2024
Q2
$2.28M Buy
267,571
+5,462
+2% +$48.5K ﹤0.01% 2831
2024
Q1
$2.68M Buy
262,109
+2,428
+0.9% +$18.1K ﹤0.01% 2814
2023
Q4
$1.42M Sell
259,681
-1,459
-0.6% -$6.39K ﹤0.01% 3160
2023
Q3
$987K Buy
261,140
+30,449
+13% +$200K ﹤0.01% 3303
2023
Q2
$1.55M Buy
230,691
+158,721
+221% +$1.06M ﹤0.01% 3164
2023
Q1
$469K Buy
71,970
+4,667
+7% +$35.9K ﹤0.01% 3496
2022
Q4
$574K Buy
67,303
+28,019
+71% +$182K ﹤0.01% 3452
2022
Q3
$207K Buy
39,284
+2,024
+5% +$9.97K ﹤0.01% 3860
2022
Q2
$158K Sell
37,260
-136,309
-79% -$475K ﹤0.01% 4009
2022
Q1
$609K Sell
173,569
-6,289
-3% -$27.4K ﹤0.01% 3665
2021
Q4
$1.2M Sell
179,858
-5,889
-3% -$47.9K ﹤0.01% 3473
2021
Q3
$1.85M Buy
185,747
+59,849
+48% +$1.48M ﹤0.01% 3330
2021
Q2
$3.89M Sell
125,898
-8,686
-6% -$278K ﹤0.01% 2990
2021
Q1
$5.87M Buy
+134,584
New +$6.37M ﹤0.01% 2656

Other funds holding SPRY